Ignite Creation Date:
2025-12-25 @ 1:07 AM
Ignite Modification Date:
2026-02-23 @ 1:11 AM
Study NCT ID:
NCT00622193
Status:
COMPLETED
Last Update Posted:
2017-04-14
First Post:
2008-02-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose Range Study of Anamorelin in Patients With Non-small Cell Lung Cancer
Sponsor:
Helsinn Therapeutics (U.S.), Inc
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ST-ANAM-207
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None